Prous Institute for Biomedical Research is a venture capital fund specializing in health tech. Founded by Dr. J.R. Prous, it evolved from Prous Science, acquired by Thomson Reuters. The institute invests in early-stage startups developing new therapies and diagnostic tools, leveraging over 60 years of expertise in life sciences. One of their investments is Connecta Therapeutics.
